Table 1 Results of the integrative analysis between DNA methylation and gene expression data in Erdheim–Chester disease.

From: Unraveling the molecular landscape of Erdheim–Chester disease: new insights from methylome and transcriptome integration

Chr

Gene

CpG

Integration

Methylation

Gene Expression

R

P (FDR)

Δβ

P (FDR)

logFC

P (FDR)

chr16

ACSF3

cg04879696

–0,34

2,28E–02

–0,01

5,94E–05

1,52

4,76E–07

chr19

CLEC11A

cg10773601

–0,38

1,90E–03

–0,05

6,64E–03

2,34

6,73E–03

cg20308817

–0,33

4,27E–02

–0,04

6,13E–04

chr17

DNAH17

cg07125124

0,39

1,38E–03

0,01

1,51E–04

4,67

6,55E–08

cg16403016

–0,41

2,33E–04

–0,03

2,52E–03

cg27174444

0,35

1,62E–02

0,04

1,42E–07

chr9

EEF1A1P5

cg17246894

–0,35

1,80E–02

0,03

1,17E–09

–2,84

5,72E–06

cg19777542

0,34

2,96E–02

–0,01

8,80E–05

chr1

EIF1AXP1

cg16109817

–0,36

8,02E–03

0,01

5,39E–11

–3,65

3,64E–05

chr16

EIF3CL

cg27416312

–0,33

4,88E–02

–0,01

5,58E–03

2,78

1,92E–05

chr12

EIF4B

cg01657380

–0,34

2,44E–02

0,01

3,75E–03

–1,00

7,84E–05

chr20

FRG1BP

cg04692312

0,50

6,83E–08

–0,15

8,17E–09

–2,26

1,35E–04

cg09798387

0,41

3,70E–04

–0,05

1,09E–03

cg14709901

0,36

9,01E–03

–0,02

6,18E–03

cg15069499

–0,46

3,66E–06

0,09

6,23E–12

cg19196320

–0,50

8,43E–08

0,09

2,98E–05

chr5

HK3

cg05017829

–0,33

3,63E–02

–0,01

5,93E–04

1,56

1,23E–03

chr6

HLA-J

cg20380424

–0,42

1,02E–04

0,05

6,75E–04

–5,25

1,99E–05

cg20408505

0,38

3,05E–03

–0,06

9,61E–06

chr6

HLA-K

cg15411272

0,34

2,42E–02

–0,19

8,06E–10

–4,89

3,65E–05

chr9

LINC00963

cg13523245

0,45

9,05E–06

0,03

1,71E–04

1,43

5,16E–04

cg14854366

–0,41

3,07E–04

–0,04

1,09E–03

cg21226933

0,43

7,87E–05

0,02

1,91E–04

chr9

LINC02908

cg19993487

–0,34

2,46E–02

–0,02

2,29E–03

1,69

3,16E–03

chr8

LRRC14

cg12574437

0,35

1,27E–02

0,02

1,86E–03

1,38

1,02E–04

chr1

LYSMD1

cg01281797

–0,44

3,71E–05

–0,02

2,49E–04

1,73

1,41E–05

chr6

MIR6891

cg08509237

–0,34

2,83E–02

0,01

6,78E–03

–1,57

7,69E–04

chr8

NAPRT

cg22097396

–0,36

9,37E–03

–0,04

3,59E–11

2,32

9,64E–05

cg25786937

–0,37

6,23E–03

–0,04

1,05E–04

chr9

NPDC1

cg26581729

–0,35

1,33E–02

–0,03

6,13E–04

2,53

6,54E–05

chr11

PRR33

cg17501754

0,34

2,13E–02

0,01

4,64E–03

9,57

1,01E–12

chr19

PWWP3A

cg14007004

0,36

7,83E–03

0,04

5,10E–03

0,99

1,33E–04

chr4

RAC1P2

cg09100767

0,36

8,02E–03

–0,02

5,28E–04

-4,11

7,16E–11

chr6

RNASET2

cg01075399

–0,39

1,01E–03

–0,03

4,08E–03

1,53

3,99E–04

cg20406979

–0,54

1,41E–09

–0,05

1,50E–05

cg20486651

–0,36

9,51E–03

–0,07

1,13E–04

cg24398081

0,35

1,82E–02

0,01

2,91E–03

cg26887226

0,36

9,04E–03

0,03

2,37E–03

chr5

SLC22A5

cg24887267

–0,34

2,04E–02

–0,01

2,13E–03

1,24

1,64E–04

chr14

SLC25A29

cg14064024

–0,57

2,26E–11

–0,05

2,72E–06

2,00

5,60E–04

chr3

STIMATE-MUSTN1

cg10525161

0,35

1,44E–02

0,01

5,99E–03

6,50

2,49E–12

chr10

STK32C

cg01807317

–0,36

9,47E–03

–0,05

1,28E–05

1,49

6,11E–05

chr16

TBC1D10B

cg16410688

0,33

4,68E–02

0,01

3,73E–04

1,23

5,60E–05

chr19

TGFB1

cg05217755

0,33

4,06E–02

0,01

1,99E–09

1,41

2,44E–05

chr22

TRIOBP

cg16774942

0,33

3,45E–02

0,00

3,30E–18

1,28

4,42E–04

cg18442977

0,34

2,16E–02

0,00

5,57E–03

  1. Only significant interactions are showed (i.e., interaction pairs in which both methylation and expression levels were independently associated to the disease and in which CpG-gene interaction had a p-value (FDR) < 0.05 in the integrative analysis by MatrixEQTL). Δβ, ratio of DNA methylation between cases and controls. Chr, chromosome. logFC, log fold change.